Literature DB >> 1844911

Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.

D Zhuang1, S Yousefi, J W Dennis.   

Abstract

The serine/threonine O-linked carbohydrates GalNAc alpha and Gal beta 1-3GalNAc alpha, referred to as Tn and T antigens, respectively, appear to be more prevalent in some human carcinomas than in surrounding tissues. Tn/T antigens may represent incomplete synthesis of O-linked oligosaccharides, due to decreased activity of specific glycosyltransferases, or alternatively, increased glycosidases activity in tumors which may expose these internal O-linked oligosaccharide sequences. To explore these possibilities, we measured UDP-Gal:GalNAc alpha-R beta 1-3 galactosyltransferase (beta 3Gal-T) and Gal beta 1-3GalNAc alpha-R beta 1-3 galactosidase in a series of human breast tumors. In addition, glycoproteins extracted from the tumors were separated by SDS-PAGE and stained with the lectins HPA (GalNAc alpha-R reactive) and PNA (Gal beta-3GalNAc alpha-R reactive). The relative levels of HPA- to PNA-reactive glycoproteins in the carcinomas correlated inversely with beta 3Gal-T activities. The results suggest that Tn antigen expression in human breast carcinoma is due in part to low beta 3Gal-T activity, a situation similar to that observed previously in haematopoietic cells of individuals with a condition called Tn syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1844911

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  6 in total

1.  Glycosylations versus conformational preferences of cancer associated mucin core.

Authors:  J Schuman; D Qiu; R R Koganty; B M Longenecker; A P Campbell
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

2.  Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.

Authors:  G D MacLean; M Reddish; R R Koganty; T Wong; S Gandhi; M Smolenski; J Samuel; J M Nabholtz; B M Longenecker
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.

Authors:  X Liu; J Sejbal; G Kotovych; R R Koganty; M A Reddish; L Jackson; S S Gandhi; A J Mendonca; B M Longenecker
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

4.  Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes.

Authors:  Giang H T Au; Wan Y Shih; Wei-Heng Shih; Linette Mejias; Vanlila K Swami; Kimberly Wasko; Ari D Brooks
Journal:  Int J Surg Oncol       Date:  2012-12-24

5.  Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker.

Authors:  Sankaranarayanan Kannan; Reddi A Lakku; Devaraj Niranjali; Kamala Jayakumar; Arulraj H Steven; V V Taralakshmi; S Chandramohan; Ramathilakam Balakrishnan; Christian Schmidt; Devaraj Halagowder
Journal:  Mol Cancer       Date:  2003-11-05       Impact factor: 27.401

Review 6.  Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer.

Authors:  Jeong Gu Kang; Jeong-Heon Ko; Yong-Sam Kim
Journal:  Proteomics       Date:  2016-05-11       Impact factor: 3.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.